Walts Alan Edmund
SEC insider (Form 3/4/5 filer). CIK 0001853544. Director at Eloxx Pharmaceuticals, Inc. (ELOX). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 8, 2026. Located in ARLINGTON, MA.
Companies Walts Alan Edmund has filed insider reports for
- Eloxx Pharmaceuticals, Inc. (ELOX): Director
Walts Alan Edmund
CIK: 0001853544
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Eloxx Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 8, 2026ELOX
Eloxx Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
8.6K shares- - Jan 24, 2026ELOX
Eloxx Pharmaceuticals, Inc.
ExerciseDirect1.9K shares- - Sep 19, 2025ELOX
Eloxx Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
395.7K shares- - Jan 24, 2025ELOX
Eloxx Pharmaceuticals, Inc.
ExerciseDirect3.8K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
AwardDirect12K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 8, 2026 | ELOX Eloxx Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 8,590 | - | - | Direct |
| Jan 24, 2026 | ELOX Eloxx Pharmaceuticals, Inc. | Exercise | 1,875 | - | $0 | Direct |
| Sep 19, 2025 | ELOX Eloxx Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 395,680 | - | - | Direct |
| Jan 24, 2025 | ELOX Eloxx Pharmaceuticals, Inc. | Exercise | 3,750 | - | $0 | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Award | 12,000 | - | $0 | Direct |
1-5 of 5 transactions